A detailed history of Legal & General Group PLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 132,791 shares of RVMD stock, worth $7.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
132,791
Previous 132,791 -0.0%
Holding current value
$7.32 Million
Previous $6.02 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$36.92 - $47.94 $76,276 - $99,044
2,066 Added 1.58%
132,791 $6.02 Million
Q2 2024

Aug 14, 2024

BUY
$30.14 - $40.68 $741,323 - $1 Million
24,596 Added 23.18%
130,725 $5.07 Million
Q1 2024

May 14, 2024

SELL
$26.56 - $33.55 $67,807 - $85,653
-2,553 Reduced 2.35%
106,129 $3.42 Million
Q4 2023

Feb 15, 2024

BUY
$18.35 - $34.12 $591,512 - $1.1 Million
32,235 Added 42.17%
108,682 $3.12 Million
Q3 2023

Nov 14, 2023

BUY
$25.17 - $35.05 $39,642 - $55,203
1,575 Added 2.1%
76,447 $2.12 Million
Q2 2023

Aug 14, 2023

SELL
$20.28 - $27.0 $18,475 - $24,597
-911 Reduced 1.2%
74,872 $2 Million
Q1 2023

May 15, 2023

BUY
$20.76 - $30.09 $270,938 - $392,704
13,051 Added 20.8%
75,783 $1.64 Million
Q4 2022

Feb 14, 2023

BUY
$17.68 - $25.53 $172,079 - $248,483
9,733 Added 18.36%
62,732 $1.49 Million
Q3 2022

Nov 14, 2022

BUY
$17.46 - $26.0 $151,744 - $225,966
8,691 Added 19.61%
52,999 $1.05 Million
Q2 2022

Aug 22, 2022

BUY
$14.54 - $27.17 $6,528 - $12,199
449 Added 1.02%
44,308 $863,000
Q1 2022

May 16, 2022

BUY
$17.31 - $26.4 $13,640 - $20,803
788 Added 1.83%
43,859 $1.12 Million
Q3 2021

Nov 15, 2021

BUY
$23.95 - $33.41 $222,064 - $309,777
9,272 Added 27.43%
43,071 $1.19 Million
Q2 2021

Aug 12, 2021

BUY
$29.0 - $47.44 $274,862 - $449,636
9,478 Added 38.97%
33,799 $1.07 Million
Q1 2021

May 17, 2021

BUY
$37.21 - $54.43 $711,343 - $1.04 Million
19,117 Added 367.35%
24,321 $1.12 Million
Q4 2020

Feb 12, 2021

SELL
$30.19 - $45.49 $21,978 - $33,116
-728 Reduced 12.27%
5,204 $206,000
Q3 2020

Nov 13, 2020

BUY
$22.61 - $34.8 $67,174 - $103,390
2,971 Added 100.34%
5,932 $206,000
Q2 2020

Aug 14, 2020

SELL
$19.65 - $39.34 $349,652 - $700,015
-17,794 Reduced 85.73%
2,961 $94,000
Q1 2020

May 14, 2020

BUY
$20.0 - $34.08 $415,100 - $707,330
20,755 New
20,755 $453,000

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $4.83B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.